240 related articles for article (PubMed ID: 12595977)
1. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis.
Nierhaus A; Montag B; Timmler N; Frings DP; Gutensohn K; Jung R; Schneider CG; Pothmann W; Brassel AK; Schulte Am Esch J
Intensive Care Med; 2003 Apr; 29(4):646-51. PubMed ID: 12595977
[TBL] [Abstract][Full Text] [Related]
2. In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates.
Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Tzimouli V; Taparkou A; Kremenopoulos G; Germenis A
Cytokine; 2002 Jun; 18(5):260-5. PubMed ID: 12161101
[TBL] [Abstract][Full Text] [Related]
3. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
4. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
[TBL] [Abstract][Full Text] [Related]
5. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro.
Kylanpaa ML; Mentula P; Kemppainen E; Puolakkainen P; Aittomaki S; Silvennoinen O; Haapiainen R; Repo H
Pancreas; 2005 Jul; 31(1):23-7. PubMed ID: 15968243
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
[TBL] [Abstract][Full Text] [Related]
7. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?
Perry SE; Mostafa SM; Wenstone R; Shenkin A; McLaughlin PJ
Intensive Care Med; 2003 Aug; 29(8):1245-52. PubMed ID: 12774155
[TBL] [Abstract][Full Text] [Related]
8. Effects of continuous high dose rhGM-CSF infusion on human monocyte activity.
Perkins RC; Vadhan-Raj S; Scheule RK; Hamilton R; Holian A
Am J Hematol; 1993 Aug; 43(4):279-85. PubMed ID: 8396850
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
[TBL] [Abstract][Full Text] [Related]
10. Influence of granulocyte-macrophage colony-stimulating factor (GM-CSF) on whole blood endotoxin responsiveness following trauma, cardiopulmonary bypass, and severe sepsis.
Flohé S; Börgermann J; Domínguez FE; Majetschak M; Lim L; Kreuzfelder E; Obertacke U; Nast-Kolb D; Schade FU
Shock; 1999 Jul; 12(1):17-24. PubMed ID: 10468047
[TBL] [Abstract][Full Text] [Related]
11. Effect of human recombinant granulocyte-macrophage colony-stimulating factor and IL-3 on the expression of surface markers of human monocyte-derived macrophages in long-term cultures.
Dimri R; Nissimov L; Keisari Y
Lymphokine Cytokine Res; 1994 Aug; 13(4):239-45. PubMed ID: 7528061
[TBL] [Abstract][Full Text] [Related]
12. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.
Joshi I; Carney WP; Rock EP
Front Immunol; 2023; 14():1130214. PubMed ID: 36825018
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function.
Smith PD; Lamerson CL; Wong HL; Wahl LM; Wahl SM
J Immunol; 1990 May; 144(10):3829-34. PubMed ID: 2185314
[TBL] [Abstract][Full Text] [Related]
14. Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study.
Drewry AM; Ablordeppey EA; Murray ET; Beiter ER; Walton AH; Hall MW; Hotchkiss RS
Crit Care; 2016 Oct; 20(1):334. PubMed ID: 27760554
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
[TBL] [Abstract][Full Text] [Related]
16. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients.
Rosenbloom AJ; Linden PK; Dorrance A; Penkosky N; Cohen-Melamed MH; Pinsky MR
Chest; 2005 Jun; 127(6):2139-50. PubMed ID: 15947332
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
[TBL] [Abstract][Full Text] [Related]
18. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients.
Tschaikowsky K; Hedwig-Geissing M; Schiele A; Bremer F; Schywalsky M; Schüttler J
Crit Care Med; 2002 May; 30(5):1015-23. PubMed ID: 12006796
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
Mayer P; Werner FJ; Lam C; Besemer J
Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
[TBL] [Abstract][Full Text] [Related]
20.
Lachmann G; Kurth J; von Haefen C; Yuerek F; Wernecke KD; Spies C
Int J Med Sci; 2017; 14(4):367-375. PubMed ID: 28553169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
